Multienzymatic Antioxidant Activity of Manganese-Based Nanoparticles for Protection against Oxidative Cell Damage

ACS Biomater Sci Eng. 2022 Feb 14;8(2):638-648. doi: 10.1021/acsbiomaterials.1c01286. Epub 2022 Jan 25.

Abstract

Oxidative stress is related to many diseases, but available clinical treatment methods are currently limited. Exploitation of enzyme-mimicking nanomaterials (nanozymes) is a promising way for scavenging reactive oxygen species (ROS) and treatment of ROS-related diseases. Herein, the catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx) mimicking activities are expressed by MnO2 nanoparticles (MnO2-BSA NPs) coated with BSA. Effective OH removal activity is also expressed by MnO2-BSA NPs at neutral pH. Apoptosis inhibition and ROS scavenging capabilities of MnO2-BSA NPs are evident on the H2O2-exposed BEAS-2B cells line. Western blot analysis indicates that MnO2-BSA NPs inhibit H2O2-induced apoptosis by mediating the expression of apoptosis-related proteins.

Keywords: MnO2; Nanozyme; antioxidant; cytoprotective effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants* / metabolism
  • Antioxidants* / pharmacology
  • Hydrogen Peroxide / pharmacology
  • Manganese / pharmacology
  • Manganese Compounds / pharmacology
  • Nanoparticles*
  • Oxidative Stress
  • Oxides / pharmacology

Substances

  • Antioxidants
  • Manganese Compounds
  • Oxides
  • Manganese
  • Hydrogen Peroxide